Sfoglia per Autore
Effetti sul ciclo cellulare e induzione di apoptosi dell'isotiocianato sulforafane su colture di cellule T-linfoblastoidi.
2006 Lenzi M.; Fimognari C.; Cantelli Forti G.; Hrelia P.
Sulforaphane increases the efficacy of doxorubicin in mouse fibroblasts characterized by p53 mutations.
2006 Fimognari C.; Nuesse M.; Lenzi M.; Sciuscio D.; Cantelli-Forti G.; Hrelia P.
Isothiocyanates as promising chemopreventive and antioxidant agents
2006 Fimognari C.; Lenzi M.; Cantelli-Forti G.; Hrelia P.
Combination of doxorubicin and sulforaphane for reversing doxorubicin-resistant phenotype in mouse fibroblasts with p53Ser220 mutation.
2007 Fimognari C.; Lenzi M.; Sciuscio D.; Cantelli Forti G.; Hrelia P.
Cell-cycle specificity of sulforaphane-mediated apoptosis in Jurkat T-leukemia cells.
2007 Fimognari C.; Lenzi M.; Sciuscio D.; Cantelli-Forti G.; Hrelia P.
Chemoprevention of Cancer by Isothiocyanates and Anthocyanins: Mechanisms of Action and Structure-Activity Relationship
2008 Fimognari C.; Lenzi M.; Hrelia P.
RNA as a new target for toxic and protective agents.
2008 Fimognari C.; Sestili P.; Lenzi M.; Bucchini A.; Cantelli-Forti G.; Hrelia P.
Interaction of the isothiocyanate sulforaphane with drug disposition and metabolism: pharmacological and toxicological implications.
2008 Fimognari C.; Lenzi M.; Hrelia P.
Induction of differentiation in human promyelocytic cells by the isothiocyanate sulforaphane.
2008 Fimognari C.; Lenzi M.; Cantelli-Forti G.; Hrelia P.
Studio del potenziale proapoptotico del sulforafane su un modello ex vivo di leucemia.
2009 LENZI M.; C. FIMOGNARI; G. CANTELLI FORTI; P. HRELIA
Combination of doxorubicin and sulforaphane for reversing doxorubicin-resistant phenotype in mice fibroblasts with p53Ser220 mutation.
2009 Lenzi M.; Fimognari C.; Cantelli-Forti G.; Hrelia P.
Protective effect of creatine against RNA damage.
2009 FIMOGNARI C.; P. SESTILI; M. LENZI; G. CANTELLI FORTI; P. HRELIA
Apoptosis and modulation of cell cycle control by bile acids in human leukemia T cells.
2009 FIMOGNARI C.; M. LENZI; G. CANTELLI FORTI; P. HRELIA
Cytotoxicity of Hemidesmus indicus extract is associated with apoptosis by activation of mitochondrial pathway and interruption of cell-cycle progression by modulation of cyclin A2 and P21 in human jurkat T cells.
2009 FIMOGNARI C.; M. LENZI; G. CANTELLI FORTI; P. HRELIA
Apoptosis induction by sulfur-containing compounds in malignant and nonmalignant human cells.
2009 Fimognari C.; Lenzi M.; Hrelia P.
Sulforaphane induces DNA single strand breaks in cultured human cells.
2010 Sestili P; Paolillo M; Lenzi M; Colombo E; Vallorani L; Casadei L; Martinelli C; Fimognari C.
Corrigendum to "Protective effect of creatine against RNA damage" [Mutat. Res. 670 (2009) 59-67] (DOI:10.1016/j.mrfmmm.2009.07.005)
2010 Fimognari C.; Sestili P.; Lenzi M.; Cantelli-Forti G.; Hrelia P.
Mitochondrial pathway mediates the antileukemic effects of Hemidesmus Indicus, a promising botanical drug.
2011 FIMOGNARI C.; M. LENZI; L. FERRUZZI; E. TURRINI; P. SCARTEZZINI; F. POLI; R. GOTTI; A. GUERRINI; G. CARULLI; V. OTTAVIANO; G. CANTELLI FORTI; P. HRELIA
Studio in vitro ed ex vivo dell’ estratto di corteccia di Castanea sativa Mill: azione citoprotettiva e cardiomodulatrice.
2011 Micucci M; Ioan P; Malaguti M; Budriesi R; Fimognari C; Lenzi M; Hrelia S; Chiarini A
Sulforaphane potentiates RNA damage induced by different xenobiotics.
2012 FIMOGNARI C.; M. LENZI; P. SESTILI; E. TURRINI; L. FERRUZZI; P. HRELIA; G. CANTELLI FORTI
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile